CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$0.55
+0.03 (+6.81%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +755.1% upside
Low Target $2.81
Average Target $4.68
High Target $5.27
Current Price $0.55
Current
$0.55
Target
$4.68
$2.81 $4.68 avg $5.27
Scenario Analysis
Bear Case
$2.81
413.4%
Low target
Base Case
$4.68
+755.1%
Avg target
Bull Case
$5.27
+862.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.13
-82.5% from high
52-Week Low
$0.58
+-4.8% from low
Target vs 52W High
$4.68
+49.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%